Distinct roles of unliganded and liganded estrogen receptors in transcriptional repression

被引:153
作者
Cvoro, A
Tzagarakis-Foster, C
Tatomer, D
Paruthiyil, S
Fox, MS
Leitman, DC [1 ]
机构
[1] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, Ctr Reprod Sci, San Francisco, CA 94143 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1016/j.molcel.2006.01.014
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
The decline in estrogen levels during menopause is associated with increased cytokine production and inflammatory diseases. Estrogens exert anti-inflammatory effects by repressing cytokine genes, such as tumor necrosis factor-alpha (TNF alpha). The mechanisms involved in transcriptional repression by estrogens are virtually unknown. Here, we used chromatin immunoprecipitation to investigate how estrogens repress the autoinduction of the TNF alpha gene. TNF alpha assembled a transcriptional activation complex at the TNF alpha promoter that includes c-jun, p50-NF kappa B, p65-NF kappa B, CBP, Hsp90, and unliganded estrogen receptor (ER). Estradiol repressed TNFa gene expression by reversing the ligand-independent activation by ER alpha and the stimulatory actions of c-jun, NF kappa B, and CBP on transcription. Silencing of GRIP1 reversed the repression of TNF alpha and other cytokine genes by estradiol, demonstrating that GRIP1 is required for transcriptional repression and can act as a corepressor. Our study demonstrates that ER alpha is a TNF alpha-induced coactivator that becomes a repressor in the presence of estradiol by recruiting GRIP1.
引用
收藏
页码:555 / 564
页数:10
相关论文
共 52 条
[1]
Transgenic mice expressing soluble tumor necrosis factor-receptor are protected against bone loss caused by estrogen deficiency [J].
Ammann, P ;
Rizzoli, R ;
Bonjour, JP ;
Bourrin, S ;
Meyer, JM ;
Vassalli, P ;
Garcia, I .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (07) :1699-1703
[2]
Estradiol repression of tumor necrosis factor-α transcription requires estrogen receptor activation function-2 and is enhanced by coactivators [J].
An, JP ;
Ribeiro, RCJ ;
Webb, P ;
Gustafsson, JÅ ;
Kushner, PJ ;
Baxter, JD ;
Leitman, DC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (26) :15161-15166
[3]
AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer [J].
Anzick, SL ;
Kononen, J ;
Walker, RL ;
Azorsa, DO ;
Tanner, MM ;
Guan, XY ;
Sauter, G ;
Kallioniemi, OP ;
Trent, JM ;
Meltzer, PS .
SCIENCE, 1997, 277 (5328) :965-968
[4]
Mechanisms of estrogen receptor signaling:: Convergence of genomic and nongenomic actions on target genes [J].
Björnström, L ;
Sjöberg, M .
MOLECULAR ENDOCRINOLOGY, 2005, 19 (04) :833-842
[5]
Molecular basis of agonism and antagonism in the oestrogen receptor [J].
Brzozowski, AM ;
Pike, ACW ;
Dauter, Z ;
Hubbard, RE ;
Bonn, T ;
Engstrom, O ;
Ohman, L ;
Greene, GL ;
Gustafsson, JA ;
Carlquist, M .
NATURE, 1997, 389 (6652) :753-758
[6]
Reciprocal recruitment of DRIP/mediator and p160 coactivator complexes in vivo by estrogen receptor [J].
Burakov, D ;
Crofts, LA ;
Chang, CPB ;
Freedman, LP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (17) :14359-14362
[7]
Cytokines in neuroinflammation and Alzheimer's disease [J].
Cacquevel, M ;
Lebeurrier, N ;
Chéenne, S ;
Vivien, D .
CURRENT DRUG TARGETS, 2004, 5 (06) :529-534
[8]
Regulation of transcription by a protein methyltransferase [J].
Chen, DG ;
Ma, H ;
Hong, H ;
Koh, SS ;
Huang, SM ;
Schurter, BT ;
Aswad, DW ;
Stallcup, MR .
SCIENCE, 1999, 284 (5423) :2174-2177
[9]
SMRT isoforms mediate repression and anti-repression of nuclear receptor heterodimers [J].
Chen, JD ;
Umesono, K ;
Evans, RM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (15) :7567-7571
[10]
Regulation of keratin 19 gene expression by estrogen in human breast cancer cells and identification of the estrogen responsive gene region [J].
Choi, I ;
Gudas, LJ ;
Katzenellenbogen, BS .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2000, 164 (1-2) :225-237